Antitrust
Notable Representations, Key Contacts
Weil’s global Antitrust team provides clients with the international reach and extensive expertise required to handle complex and rapidly shifting antitrust and foreign investment rules around the world. Our team has a proven track record of achieving successful and innovative outcomes for clients across the full range of transactional and behavioral antitrust and foreign investment matters.
“An exceptional group of attorneys with deep experience representing clients before government agencies.”
Antitrust M&A:
With our deep experience in handling complex cross-border merger review processes and our position at the forefront of shaping antitrust policy, Weil has been trusted to provide effective global strategic counseling, agency representation, and litigation defense for many of the largest, highest-profile transactions in recent years.
Antitrust Litigation:
Weil has a strong reputation for successfully defending clients in their most high-stakes civil and criminal antitrust litigations, achieving the best outcomes at trial and on appeal in respect of the full range of cutting-edge antitrust issues, with particular success in class action litigations.
Cartels & Investigations:
With our deep expertise and global reach, Weil is regularly called upon by clients across the globe to guide them through all phases of criminal and civil cartel investigations. We have consistently obtained favorable results, earning the practice recognition among the top cartel defense firms in the world.
Global Recognition
50
Key Contacts
Shortcut Links
Awards and Recognition, Speaking Engagements, Latest Thinking, Firm News & Announcements
Awards and Recognition
- Weil Ranked a Top-Ranked Tier 1 Firm for Antitrust in the U.S. Award Brief — Benchmark Litigation 2022
- Eric Hochstadt Named 2019 "Rising Star" Award Brief — New York Law Journal
- Jeff White Named 2018 Rising Star for Antitrust/Competition by Law360 Award Brief — Law360 2018
- Weil Named “Antitrust Firm of the Year” Award Brief — Legal Media Group’s Sixth Annual Life Sciences Awards, 2018
- David Lender and Eric Hochstadt Named AmLaw’s Litigators of the Week Award Brief — The Am Law Litigation Daily April 2018
Speaking Engagements
-
The Robinson-Patman Act: The Potential Revival of a Controversial Law from the Dustbins of History
Speaker(s):
Yehudah L. Buchweitz
May 2, 2024 — New York, NY — Weil Complex Commercial Litigation partner Yehudah Buchweitz led a panel discussion entitled “The Robinson-Patman Act: The Potential Revival of a Controversial Law from the Dustbins of History,” at Practising Law Institute’s “Developments in Antitrust Law & Regulation 2024.” The panel touched on the history of the Robinson-Patman Act, key considerations in bringing and defending against claims under it, and the dynamics between the Robinson-Patman Act and other antitrust laws
-
A Divided FTC Issues Final Rule on Non-Competes
Speaker(s):
John P. Barry,
Eric S. Hochstadt and
Celine Chan
April 29, 2024 — Weil partners John Barry and Eric Hochstadt and counsel Celine Chan moderated a cross-disciplinary Weil webinar entitled “A Divided FTC Issues Final Rule on Non-Competes,” in which they analyzed the FTC’s Final Rule and legal challenges to it, and provided practical takeaways for employers.
Latest Thinking
- A Divided FTC Issues Final Rule on Non-Competes – Caution is Warranted Although the Rule May Not Survive Legal Challenges Alert — Weil Alert — By John P. Barry, Jeffrey H. Perry, Eric S. Hochstadt and Mark A. Perry — PDF — April 24, 2024
- Litigation Trends 2024 Publication — By Weil’s Litigation Department — Spring 2024
-
Making Greener Choices: Growing the Role of Sustainability in Global Merger Reviews
Blog Post — WorthWeil Antitrust Blog
— By
Nafees Saeed,
Kristin Sanford,
Bella Spring and
Clémence Coppin
— April 02, 2024
With growing demand for greener choices, environmental sustainability considerations are playing a more important role in merger reviews. What are the practical takeaways for global deal strategy and timing? ...
-
Antitrust Scrutiny of “Roll Up” Strategies Heats Up as US Agencies Examine Private Equity Healthcare Deals
Blog Post — WorthWeil Antitrust Blog
— By
Michael Moiseyev,
Nafees Saeed,
Bella Spring and
Spencer Talbot
— March 12, 2024
The FTC and Chair Khan are continuing their efforts to spotlight their concerns about private equity ownership of hospitals and other healthcare facilities. With increased antitrust scrutiny of “roll-up” strategies happening on both sides of the Atlantic, in this post we explain the latest developments. ...
-
Client Alert: “Charting competitive landscapes”: European Commission adopts revised market definition guidance to boost antitrust compliance
Blog Post — WorthWeil Antitrust Blog
— By
Niklas Maydell,
Neil Rigby and
Bella Spring
— February 13, 2024
After much anticipation, the European Commission has adopted its revised Market Definition Notice – the first revision of the Notice since its adoption in 1997. The revised Notice reflects significant developments in market realities over the intervening years – especially the impact of digitalisation and the increasingly interconnected and globalised nature of many commercial dealings. ...
Firm News & Announcements
- Weil Advises Pacific Avenue Capital Partners in its Acquisition of Sogefi’s Filtration Business Deal Brief — May 07, 2024
- Weil Advises CFGI on Agreement to Acquire PAS Financial Advisory AG Deal Brief — May 06, 2024